Inside the off-grid Russian village where dead Wagner mercenaries demand to be buried dailystar.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailystar.co.uk Daily Mail and Mail on Sunday newspapers.
Science’s COVID-19 reporting is supported by the Heising-Simons Foundation.
When the Kremlin last month said Russian President Vladimir Putin had received the first dose of a homegrown COVID-19 vaccine, a guessing game began. Had he gotten Sputnik V, which Russia had given emergency use authorization a world first in August 2020 after testing in just 79 patients? Or had Putin been given another COVID-19 vaccine that Russia had sanctioned with much less fanfare and with equally sparse evidence that it works?
Putin and state officials wouldn’t say, but Russia’s second COVID-19 vaccine, known as EpiVacCorona and first authorized in October 2020, has begun to emerge from the shadow of Sputnik V, bringing controversy of its own. Developed by VECTOR, the famed State Research Center of Virology and Biotechnology that once studied bioweapons and now is one of two global repositories of the eradicated smallpox virus, the vaccine is key to the country’s plans to combat the pandemic.
Full article Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow s Gamaleya Institute
Russia approved a third coronavirus vaccine for domestic use, Prime Minister Mikhail Mishustin said on state TV, though large-scale clinical trials of the shot, labeled CoviVac and produced by the Chumakov Centre, have yet to begin.
Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow s Gamaleya Institute, following a similar approach of granting approval before seeing any late-stage trial results.
The pre-emptive approvals had raised concerns among some scientists in the West, but inoculations with those first two shots began on a mass scale in Russia only after trials were concluded and showed success.
Read more about Russia approves its third Covid-19 vaccine for domestic use: PM Mishustin on Business Standard. Russia has already approved two Covid-19 vaccines, including the Sputnik V shot, developed by Moscow s Gamaleya Institute